This was the stock's fourth consecutive day of losses.

BofA analyst Allen Lutz double upgraded Henry Schein (HSIC) to Buy from Underperform with a price target of $84, up from $69. The firm believes ...

BofA upgraded Henry Schein (HSIC) to Buy from Underperform on January 6, not tonight as previously reported in error.Maximize Your Portfolio ...

This belief drove our collaboration with Henry Schein One, a division of Henry Schein, a leader in dental software solutions, to launch a dynamic new website designed to set the standard for ...

Henry Schein said it expects to report earnings and revenue growth in the fourth quarter and forecast further gains in 2025 adjusted earnings, even as it confirmed an activist-investment deal with ...

Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Henry Schein HSIC in the last three months. The table below offers a condensed view of their ...

NEW YORK (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein, arguing the dental and medical distributor needs ...

NEW YORK, Jan 22 (Reuters) - Activist investor Ananym Capital Management plans to nominate as many as half a dozen directors to the board at Henry Schein (HSIC.O), opens new tab, arguing the ...

Henry Schein, Inc. (NASDAQ:HSIC) shares are trading higher on Wednesday. The medical and dental supplies distributor disclosed a strategic investment of an additional $250 million from funds ...

MELVILLE, N.Y.--(BUSINESS WIRE)-- Henry Schein, Inc. (Nasdaq: HSIC) (“Henry Schein” or the “Company”), the world’s largest provider of health care solutions to office-based dental and ...

(Reuters) -Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the distributor of medical products said on Wednesday. Shares of ...